FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109948637> ?p ?o ?g. }

• W2109948637 endingPage "4945" @default.
• W2109948637 startingPage "4938" @default.
• W2109948637 abstract "Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (HSCT). Patients and Methods We retrospectively analyzed the data of 399 patients with AML in first hematological relapse after HSCT whose treatment did (n = 171) or did not (n = 228) include DLI. After correction for imbalances and established risk factors, the two groups were compared with respect to overall survival. Further, a detailed analysis of risk factors for survival among DLI recipients was performed. Results Median follow-up was 27 and 40 months, respectively. Estimated survival at 2 years (± standard deviation) was 21% ± 3% for patients receiving DLI and 9% ± 2% for patients not receiving DLI. After adjustment for differences between the groups, better outcome was associated with age younger than 37 years (P = .008), relapse occurring more than 5 months after HSCT (P < .0001), and use of DLI (P = .04). Among DLI recipients, a lower tumor burden at relapse (< 35% of bone marrow blasts; P = .006), female sex (P = .02), favorable cytogenetics (P = .004), and remission at time of DLI (P < .0001) were predictive for survival in a multivariate analysis. Two-year survival was 56% ± 10%, if DLI was performed in remission or with favorable karyotype, and 15% ± 3% if DLI was given in aplasia or with active disease. Conclusion Although further evidence for a graft-versus-leukemia effect by DLI is provided, our results confirm, that the clinical benefit is limited to a minority of patients. Strategies to reduce tumor burden before DLI, as well as alternative treatment options should be investigated in adults with relapsed AML after HSCT." @default.
• W2109948637 created "2016-06-24" @default.
• W2109948637 creator A5003544803 @default.
• W2109948637 creator A5007202804 @default.
• W2109948637 creator A5013640134 @default.
• W2109948637 creator A5017002895 @default.
• W2109948637 creator A5019072713 @default.
• W2109948637 creator A5026106615 @default.
• W2109948637 creator A5026849709 @default.
• W2109948637 creator A5034673327 @default.
• W2109948637 creator A5035666187 @default.
• W2109948637 creator A5037737991 @default.
• W2109948637 creator A5038588053 @default.
• W2109948637 creator A5040417184 @default.
• W2109948637 creator A5058365219 @default.
• W2109948637 creator A5058925624 @default.
• W2109948637 creator A5086668079 @default.
• W2109948637 creator A5088499007 @default.
• W2109948637 date "2007-11-01" @default.
• W2109948637 modified "2023-10-17" @default.
• W2109948637 title "Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party" @default.
• W2109948637 cites W1274344746 @default.
• W2109948637 cites W1492609361 @default.
• W2109948637 cites W1545991364 @default.
• W2109948637 cites W1707184873 @default.
• W2109948637 cites W1873141201 @default.
• W2109948637 cites W1961045948 @default.
• W2109948637 cites W1972220493 @default.
• W2109948637 cites W1976481261 @default.
• W2109948637 cites W2013051826 @default.
• W2109948637 cites W2015154203 @default.
• W2109948637 cites W2019326887 @default.
• W2109948637 cites W2028397809 @default.
• W2109948637 cites W2033857851 @default.
• W2109948637 cites W2036116596 @default.
• W2109948637 cites W2046478477 @default.
• W2109948637 cites W2055033291 @default.
• W2109948637 cites W2056164283 @default.
• W2109948637 cites W2058833974 @default.
• W2109948637 cites W2065406906 @default.
• W2109948637 cites W2068700346 @default.
• W2109948637 cites W2078412696 @default.
• W2109948637 cites W2084267226 @default.
• W2109948637 cites W2100515276 @default.
• W2109948637 cites W2147773887 @default.
• W2109948637 cites W2150917826 @default.
• W2109948637 cites W2257559310 @default.
• W2109948637 cites W2297816245 @default.
• W2109948637 cites W2315152253 @default.
• W2109948637 cites W3147894994 @default.
• W2109948637 cites W4235603422 @default.
• W2109948637 cites W4254299890 @default.
• W2109948637 cites W4293241248 @default.
• W2109948637 cites W44995847 @default.
• W2109948637 doi "https://doi.org/10.1200/jco.2007.11.6053" @default.
• W2109948637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17909197" @default.
• W2109948637 hasPublicationYear "2007" @default.
• W2109948637 type Work @default.
• W2109948637 sameAs 2109948637 @default.
• W2109948637 citedByCount "428" @default.
• W2109948637 countsByYear W21099486372012 @default.
• W2109948637 countsByYear W21099486372013 @default.
• W2109948637 countsByYear W21099486372014 @default.
• W2109948637 countsByYear W21099486372015 @default.
• W2109948637 countsByYear W21099486372016 @default.
• W2109948637 countsByYear W21099486372017 @default.
• W2109948637 countsByYear W21099486372018 @default.
• W2109948637 countsByYear W21099486372019 @default.
• W2109948637 countsByYear W21099486372020 @default.
• W2109948637 countsByYear W21099486372021 @default.
• W2109948637 countsByYear W21099486372022 @default.
• W2109948637 countsByYear W21099486372023 @default.
• W2109948637 crossrefType "journal-article" @default.
• W2109948637 hasAuthorship W2109948637A5003544803 @default.
• W2109948637 hasAuthorship W2109948637A5007202804 @default.
• W2109948637 hasAuthorship W2109948637A5013640134 @default.
• W2109948637 hasAuthorship W2109948637A5017002895 @default.
• W2109948637 hasAuthorship W2109948637A5019072713 @default.
• W2109948637 hasAuthorship W2109948637A5026106615 @default.
• W2109948637 hasAuthorship W2109948637A5026849709 @default.
• W2109948637 hasAuthorship W2109948637A5034673327 @default.
• W2109948637 hasAuthorship W2109948637A5035666187 @default.
• W2109948637 hasAuthorship W2109948637A5037737991 @default.
• W2109948637 hasAuthorship W2109948637A5038588053 @default.
• W2109948637 hasAuthorship W2109948637A5040417184 @default.
• W2109948637 hasAuthorship W2109948637A5058365219 @default.
• W2109948637 hasAuthorship W2109948637A5058925624 @default.
• W2109948637 hasAuthorship W2109948637A5086668079 @default.
• W2109948637 hasAuthorship W2109948637A5088499007 @default.
• W2109948637 hasBestOaLocation W21099486371 @default.
• W2109948637 hasConcept C126322002 @default.
• W2109948637 hasConcept C143998085 @default.
• W2109948637 hasConcept C2777408962 @default.
• W2109948637 hasConcept C2778461978 @default.
• W2109948637 hasConcept C2778729363 @default.
• W2109948637 hasConcept C2779695342 @default.
• W2109948637 hasConcept C2911091166 @default.
• W2109948637 hasConcept C38180746 @default.

• next